H.C. Wainwright Reiterates Buy Rating on Immunitybio Inc (IBRX)

October 15, 2026 6:57 AM

H.C. Wainwright analyst Andres Maldonado reiterated a Buy rating and $15.00 price target on Immunitybio Inc (NASDAQ: IBRX).The analyst commented ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found